Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin for large patent ductus arteriosus in very preterm infants
ACTRN12607000532404Phase 2Recruiting
- Sponsor
- Dr David Knight
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in patent ductus arteriosus (PDA) comparing Indomethacin with Placebo (2 arms). Primary endpoints: Chronic lung disease and Death. Started Aug 2007; status: recruiting.
02
Drugs
indomethacin
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on ACTRN12607000532404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000532404.